These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1360807)

  • 1. Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects.
    Danjou P; Molinier P; Berlin I; Patat A; Rosenzweig P; Morselli PL
    Br J Clin Pharmacol; 1992 Oct; 34(4):328-31. PubMed ID: 1360807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects.
    Patat A; Stubbs D; Dunmore C; Ulliac N; Sexton B; Zieleniuk I; Irving A; Jones W
    Eur J Clin Pharmacol; 1995; 48(2):143-50. PubMed ID: 7589029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1-receptor antagonist.
    Chaufour S; Caplain H; Lilienthal N; L'héritier C; Deschamps C; Dubruc C; Rosenzweig P
    Br J Clin Pharmacol; 1999 May; 47(5):515-20. PubMed ID: 10336575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of subsensitivity to mizolastine over 8-week treatment.
    Bousquet J; Chanal I; Murrieta M; Stalla-Bourdillon A
    Allergy; 1996 Apr; 51(4):251-6. PubMed ID: 8792922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
    Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
    Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.
    Rosenzweig P; Thebault JJ; Caplain H; Dubruc C; Bianchetti G; Fuseau E; Morselli PL
    Ann Allergy; 1992 Aug; 69(2):135-9. PubMed ID: 1354949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
    Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat.
    Pichat P; Angel I; Arbilla S
    Arzneimittelforschung; 1998 Feb; 48(2):173-8. PubMed ID: 9541729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of mizolastine on the safety and pharmacokinetics of digoxin administered orally in repeated doses to healthy volunteers.
    Chaufour S; Le Coz F; Denolle T; Dubruc C; Cimarosti I; Deschamps C; Ulliac N; Delhotal-Landes B; Rosenzweig P
    Int J Clin Pharmacol Ther; 1998 May; 36(5):286-91. PubMed ID: 9629994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
    Simons FE
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers.
    Vuurman EF; Uiterwijk MM; Rosenzweig P; O'Hanlon JF
    Eur J Clin Pharmacol; 1994; 47(3):253-9. PubMed ID: 7867678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central cholinergic pathway involvement in the regulation of pupil diameter, blink rate and cognitive function.
    Naicker P; Anoopkumar-Dukie S; Grant GD; Neumann DL; Kavanagh JJ
    Neuroscience; 2016 Oct; 334():180-190. PubMed ID: 27531858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QT interval monitoring during clinical studies with mizolastine, a new H1 antihistamine.
    Delauche-Cavallier MC; Chaufour S; Guérault E; Lacroux A; Murrieta M; Wajman A
    Clin Exp Allergy; 1999 Jul; 29 Suppl 3():206-11. PubMed ID: 10444239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mizolastine, a novel selective histamine H1 receptor antagonist: lack of sedative potential on the EEG in the rodent.
    Depoortere H; Decobert M; Granger P; Françon D
    Neuropsychobiology; 1995; 32(4):214-21. PubMed ID: 8587704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mizolastine in vitro on human immunocompetent and airway cells: evidence for safety and additional property.
    Oddera S; Cagnoni F; Dellacasa P; Canonica GW
    Int Arch Allergy Immunol; 2000 Oct; 123(2):162-9. PubMed ID: 11060489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers.
    Kerr JS; Dunmore C; Hindmarch I
    Eur J Clin Pharmacol; 1994; 47(4):331-5. PubMed ID: 7875184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.